highlight / actuality
New therapeutic proposal and novel preclinical model to study cancer development and progression
Researchers from the Cancer Biology and Infection laboratory study choriocarcinoma and demonstrate the involvement of placental factor EG-VEGF in the development of this very aggressive cancer of pregnancy. They also offer less toxic therapies than those currently used chemotherapies, using the therapeutic potential of two EG-VEGF antagonists.que les chimiothérapies actuellement utilisées, en utilisant le potentiel thérapeutique de deux antagonistes d’EG-VEGF.
Thesis presented on December 12, 2016 by Wael Traboulsi. PhD thesis available as a pdf file.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.